Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Revance Therapeutics Company Profile (NASDAQ:RVNC)

Consensus Ratings for Revance Therapeutics (NASDAQ:RVNC) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $35.00 (37.42% upside)

Analysts' Ratings History for Revance Therapeutics (NASDAQ:RVNC)
Show:
DateFirmActionRatingPrice TargetActions
12/9/2014William BlairInitiated CoverageOutperform$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014BMO Capital MarketsInitiated CoverageOutperform$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Cowen and CompanyInitiated CoverageOutperform$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Piper JaffrayInitiated CoverageOverweight$44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2013 forward)